Jemperli trial continues to show positive results for deficient (dMMR) rectal cancer
Updated analysis from Memorial Sloan Kettering Cancer Center presented at ASCO 2024 has expanded to 42 patients with clinical complete response
Updated analysis from Memorial Sloan Kettering Cancer Center presented at ASCO 2024 has expanded to 42 patients with clinical complete response
For use with Hamamatsu Images acquired with the NanoZoomer S360MD slide scanner
Commercial terms include research funding and milestones and/or royalty payments to Evotec based on the success of the program
Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2
TriClip offers a remarkably safe, minimally invasive treatment option for patients in need of tricuspid valve repair but who are unable to withstand surgery
Lunaphore's flagship COMET technology is the only fully-automated, high-throughput, hyperplex platform with superior tissue profiling capabilities
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion diagnostics business.
Launches collaborative centre for translational research in head and neck cancer
Subscribe To Our Newsletter & Stay Updated